 Analgesics
|
Anesthetics
|
Anti-Addiction/Substance Abuse Treatment Agents
|
Antibacterials
|
Anticonvulsants
|
Antidementia Agents
|
Antidepressants
|
Antiemetics
|
Antifungals
|
Antigout Agents
|
Antimigraine Agents
|
Antimyasthenic Agents
|
Antimycobacterials
|
 Antineoplastics
|
Alkylating Agents
|
Antiandrogens
|
Antiangiogenic Agents
|
Antiestrogens/Modifiers
|
Antimetabolites
|
Aromatase Inhibitors, 3rd Generation
|
Enzyme Inhibitors
|
Molecular Target Inhibitors
|
Monoclonal Antibody/Antibody-Drug Conjugate
|
Retinoids
|
Treatment Adjuncts
|
Antineoplastics, Other
|
Methotrexate [DG:DG00681]
|
 D00142 Methotrexate (JP17/USP/INN)
D02115 Methotrexate sodium
|
Pemetrexed [DG:DG00682]
|
Aldesleukin
|
Asparaginase-erwinia
|
Calaspargase pegol
|
Denileukin Diftitox
|
Enasidenib [DG:DG02837]
|
Fludarabine [DG:DG00685]
|
Ixazomib [DG:DG01269]
|
Letrozole/ Ribociclib
|
Leucovorin [DG:DG02073]
|
Levoleucovorin [DG:DG03003]
|
Mitoxantrone [DG:DG00701]
|
Pegaspargase
|
Selinexor
|
Tagraxofusp
|
Trifluridine/ Tipiracil
|
Uridine
|
Vorinostat
|
Anti-Obesity Agents
|
Antiparasitics
|
Antiparkinson Agents
|
Antipsychotics
|
Antispasticity Agents
|
Antivirals
|
Anxiolytics
|
Bipolar Agents
|
Blood Glucose Regulators
|
Blood Products and Modifiers
|
Cardiovascular Agents
|
Central Nervous System Agents
|
Contraceptives
|
Dental and Oral Agents
|
Dermatological Agents
|
Electrolytes/Minerals/Metals/Vitamins
|
Gastrointestinal Agents
|
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
|
Genitourinary Agents
|
Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
|
Hormonal Agents, Suppressant (Adrenal)
|
Hormonal Agents, Suppressant (Pituitary)
|
Hormonal Agents, Suppressant (Thyroid)
|
Immunological Agents
|
Angioedema Agents
|
Immunosuppressants
|
Antimetabolites, Antiproliferative
|
Leflunomide
|
Methotrexate [DG:DG00681]
|
D00142 Methotrexate (JP17/USP/INN)
D02115 Methotrexate sodium
|
Mycophenolic Acid [DG:DG00739]
|
Antimetabolites, Purine
|
Calcineurin Inhibitors
|
Interleukin-2 Inhibitors
|
mTOR Inhibitors
|
Tumor Necrosis Factor (TNF) Blockers
|
Immunosupressants, Other
|
Mercaptopurine [DG:DG00683]
|
Pimecrolimus
|
Immunostimulants
|
Immunoglobulins
|
Immunological Agents, Other
|
Vaccines
|
Infertility Agents
|
Inflammatory Bowel Disease Agents
|
Metabolic Bone Disease Agents
|
Ophthalmic Agents
|
Otic Agents
|
Respiratory Tract/Pulmonary Agents
|
Sexual Disorder Agents
|
Skeletal Muscle Relaxants
|
Sleep Disorder Agents
|
USP Drug Classification